Want to see IN:FAIRCHEMOR full AI Analyst Report?
Top Page
Fairchem Organics Ltd
(FAIRCHEMOR)
Select Model
Select Model
Rating:51Neutral
Price Target:
₹676.00
▼(-11.76% Downside)
Action:Reiterated
Date:07/02/26
The score is primarily held back by weakening financial performance (sharp margin/ROE deterioration) and a demanding valuation (very high P/E). These negatives are partially offset by strong current price momentum with the stock trading above key moving averages and supported by positive MACD.
Positive Factors
Diversified Specialty-Chemicals Applications
Exposure to multiple industrial and consumer-linked applications reduces reliance on one end market. Its specialty oleochemical portfolio can support longer-term customer relevance and product-mix opportunities across diverse sectors.
Negative Factors
Revenue Decline and Margin Compression
Shrinking revenue combined with sharply lower margins signals pressure from costs, pricing, or product mix. Sustained weakness would reduce internal funding, limit operating resilience, and make recovery dependent on improved demand or execution.
Read all positive and negative factors
Positive Factors
Negative Factors
Diversified Specialty-Chemicals Applications
Exposure to multiple industrial and consumer-linked applications reduces reliance on one end market. Its specialty oleochemical portfolio can support longer-term customer relevance and product-mix opportunities across diverse sectors.
Read all positive factors
Fairchem Organics Ltd (FAIRCHEMOR) vs. iShares MSCI India ETF (INDA)
Market Cap
₹8.40B
Dividend Yield0.15%
Average Volume (3M)1.98K
Price to Earnings (P/E)59.6
Beta (1Y)0.08
Revenue Growth0.14%
EPS Growth58.54%
CountryIN
Employees212
SectorGeneral
Sector StrengthN/A
IndustryChemicals - Specialty
Share Statistics
EPS (TTM)4.27
Shares Outstanding12,595,902
10 Day Avg. Volume858
30 Day Avg. Volume1,976
Financial Highlights & Ratios
PEG Ratio-1.36
Price to Book (P/B)2.13
Price to Sales (P/S)1.22
P/FCF Ratio24.46
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Fairchem Organics Ltd Business Overview & Revenue Model
Company Description
Fairchem Organics Limited, headquartered in Ahmedabad, India, was founded in 2019. This company specializes in the manufacturing and worldwide sale of sophisticated oleochemicals and key nutraceutical components. Its market reach extends across In...
How the Company Makes Money
Fairchem Organics primarily makes money by selling specialty oleochemicals and related chemical products to business customers (B2B). Revenue is generated from (1) manufacturing and sale of oleochemical derivatives and specialty additives—where th...
Fairchem Organics Ltd Financial Statement Overview
Summary
Income Statement
34
Negative
Balance Sheet
63
Positive
Cash Flow
52
Neutral
| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 4.60B | 5.38B | 6.21B | 6.47B | 6.42B |
| Gross Profit | 355.37M | 666.52M | 1.54B | 1.56B | 1.78B |
| EBITDA | 220.40M | 441.21M | 681.10M | 729.68M | 1.05B |
| Net Income | 55.41M | 219.74M | 405.00M | 435.01M | 679.06M |
Balance Sheet | |||||
| Total Assets | 3.91B | 4.02B | 3.34B | 3.42B | 3.24B |
| Cash, Cash Equivalents and Short-Term Investments | 12.26M | 12.86M | 84.00K | 838.00K | 83.00K |
| Total Debt | 837.82M | 630.32M | 73.18M | 501.68M | 620.30M |
| Total Liabilities | 1.28B | 997.98M | 443.77M | 831.48M | 919.26M |
| Stockholders Equity | 2.63B | 3.02B | 2.90B | 2.59B | 2.32B |
Cash Flow | |||||
| Free Cash Flow | 229.13M | -464.87M | 563.52M | 348.89M | 58.91M |
| Operating Cash Flow | 382.54M | -203.78M | 744.80M | 496.15M | 404.85M |
| Investing Cash Flow | -140.95M | -255.71M | -176.25M | -144.92M | -341.84M |
| Financing Cash Flow | -241.53M | 459.49M | -568.55M | -351.24M | -63.19M |
Fairchem Organics Ltd Technical Analysis
Negative
766.10
Price Trends
713.89
Negative
651.97
Positive
640.02
Positive
Market Momentum
-15.59
Positive
42.24
Neutral
62.68
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:FAIRCHEMOR, the sentiment is Negative. The current price of 766.1 is above the 20-day moving average (MA) of 693.26, above the 50-day MA of 713.89, and above the 200-day MA of 640.02, indicating a neutral trend. The MACD of -15.59 indicates Positive momentum. The RSI at 42.24 is Neutral, neither overbought nor oversold. The STOCH value of 62.68 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:FAIRCHEMOR.
Fairchem Organics Ltd Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ₹189.82B | 24.00 | ― | 0.41% | 15.75% | 59.22% | |
69 Neutral | ₹102.80B | 44.87 | ― | 0.62% | 5.11% | 20.64% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
53 Neutral | ₹110.41B | 34.98 | ― | 0.74% | 10.96% | 11.16% | |
53 Neutral | ₹45.68B | 37.43 | ― | 0.16% | 5.47% | 24.88% | |
51 Neutral | ₹8.40B | 59.56 | ― | 1.07% | 0.14% | 58.54% | |
45 Neutral | ₹190.30B | 34.48 | ― | 0.20% | 27.05% | 123.98% |
* General Sector Average
IN:FAIRCHEMOR
Fairchem Organics Ltd
670.00
-124.66
-15.69%
IN:AARTIIND
AARTI Industries Ltd
505.45
120.15
31.18%
IN:ALKYLAMINE
Alkyl Amines Chemicals Limited
1,976.90
-124.00
-5.90%
IN:ATUL
Atul Limited
6,484.40
98.08
1.54%
IN:JUBLINGREA
Jubilant Ingrevia Ltd.
683.25
-43.05
-5.93%
IN:LXCHEM
Laxmi Organic Industries Ltd.
169.80
-46.88
-21.64%
Fairchem Organics Ltd Corporate Events
Fairchem Organics Publishes Q1 FY27 Unaudited Results Extract in Financial Dailies
Jul 28, 2026
Fairchem Organics Ltd has notified the stock exchanges that its Board of Directors approved the unaudited financial results for the quarter ended June 30, 2026, at a meeting held on July 27, 2026. In line with regulatory requirements, an extract o...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.